An AI model using mammogram images predicts 5-year breast cancer risk more accurately than traditional breast density assessment.
Key Details
- 1The study is presented at the RSNA annual meeting in Chicago.
- 2Clairity Breast, the first FDA-authorized image-only AI breast cancer risk model, was trained on over 421,000 mammograms.
- 3AI model performance was evaluated on more than 245,000 screening mammograms from the US and Europe.
- 4Women in the AI high-risk group had a >4x higher incidence of cancer (5.9%) than average-risk (1.3%), while density-based separation was modest (3.2% vs. 2.7%).
- 5Findings support integrating image-only AI risk scores with traditional risk factors for more personalized screening strategies.
Why It Matters
This research advances precision screening in breast imaging, offering radiologists a more nuanced, data-driven tool for risk stratification. Early identification of high-risk patients via AI could lead to tailored screening protocols and improved outcomes.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.